Pharmacy- Page 9

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

Novo Nordisk increased reported operating profit by 1% in 2017 to DKK 49 billion

The FINANCIAL -- Sales within biopharmaceuticals declined by 18% to DKK 18.8 billion (16% in local currencies), reflecting the impact in the USA from the introduction of a generic version of the hormone replacement therapy product Vagifem and a rebate adjustment for

by The FINANCIAL

February 1, 2018

1 min read

Pharmacy

Roche 2017 profit falls on impairments

The FINANCIAL -- Commenting on the Group’s results, Roche CEO Severin Schwan said: “In 2017, we made significant progress with good growth in both divisions driven by newly launched medicines and tests. I am particularly pleased with the successful launch of Ocrevus

by The FINANCIAL

February 1, 2018

5 mins read

Pharmacy

Eli Lilly And Co. Profit Rises In Q4

The FINANCIAL -- Eli Lilly and Company on January 31 announced financial results for the fourth quarter and full year of 2017.

by The FINANCIAL

January 31, 2018

14 mins read

Pharmacy

High levels of antibiotic resistance found worldwide, new data shows

The FINANCIAL -- WHO’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries.

by The FINANCIAL

January 30, 2018

2 mins read

Pharmacy

Sanofi to acquire Ablynx for €3.9 Billion

The FINANCIAL -- Sanofi and Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies, entered into a definitive agreement under which Sanofi will offer to acquire all of the outstanding ordinary shares, including shares represented by American Depositary Shares

by The FINANCIAL

January 29, 2018

3 mins read

Pharmacy

AbbVie’s profit beats estimates on strong Humira sales, raises 2018 forecast

The FINANCIAL -- AbbVie announced financial results for the fourth quarter ended December 31, 2017.

by The FINANCIAL

January 26, 2018

6 mins read

Pharmacy

Concerning ill patients: Should they stay, or should they go?

The FINANCIAL -- America's influenza epidemic is at its peak, making it especially important for optometric practices to take extra precautions to prevent the spread of illness.

by The FINANCIAL

January 25, 2018

2 mins read

Pharmacy

Abbott shares up on Q4, 2017 earnings beat

The FINANCIAL -- Abbott on January 24 announced financial results for the fourth quarter ended Dec. 31, 2017.

by The FINANCIAL

January 25, 2018

5 mins read

Pharmacy

Johnson & Johnson beats earnings, revenue expectations

The FINANCIAL -- Johnson & Johnson on January 23 announced sales of $20.2 billion for the fourth quarter of 2017, an increase of 11.5% as compared to the fourth quarter of 2016.

by The FINANCIAL

January 23, 2018

5 mins read

Pharmacy

European Commission Approves Bristol-Myers Squibb’s Yervoy

The FINANCIAL -- Bristol-Myers Squibb Company announced on Januray 22 that the European Commission (EC) has expanded the indication of Yervoy (ipilimumab) to include treatment of advanced (unresectable or metastatic) melanoma in pediatric patients 12 years of age and older.

by The FINANCIAL

January 23, 2018

1 min read